nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftizoxime—Phlebitis—Carboplatin—uterine cancer	0.0337	0.0337	CcSEcCtD
Ceftizoxime—Tenderness—Progesterone—uterine cancer	0.0241	0.0241	CcSEcCtD
Ceftizoxime—Induration—Etoposide—uterine cancer	0.024	0.024	CcSEcCtD
Ceftizoxime—Injection site pain—Medroxyprogesterone Acetate—uterine cancer	0.0233	0.0233	CcSEcCtD
Ceftizoxime—Tenderness—Medroxyprogesterone Acetate—uterine cancer	0.0218	0.0218	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Progesterone—uterine cancer	0.021	0.021	CcSEcCtD
Ceftizoxime—Vaginal infection—Progesterone—uterine cancer	0.0198	0.0198	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Medroxyprogesterone Acetate—uterine cancer	0.019	0.019	CcSEcCtD
Ceftizoxime—Nephropathy toxic—Etoposide—uterine cancer	0.0187	0.0187	CcSEcCtD
Ceftizoxime—Vaginal infection—Medroxyprogesterone Acetate—uterine cancer	0.018	0.018	CcSEcCtD
Ceftizoxime—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.0153	0.0153	CcSEcCtD
Ceftizoxime—Prothrombin level increased—Epirubicin—uterine cancer	0.0147	0.0147	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Dactinomycin—uterine cancer	0.0139	0.0139	CcSEcCtD
Ceftizoxime—Prothrombin level increased—Doxorubicin—uterine cancer	0.0136	0.0136	CcSEcCtD
Ceftizoxime—Numbness—Etoposide—uterine cancer	0.013	0.013	CcSEcCtD
Ceftizoxime—Phlebitis—Dactinomycin—uterine cancer	0.0125	0.0125	CcSEcCtD
Ceftizoxime—Sensory loss—Etoposide—uterine cancer	0.0124	0.0124	CcSEcCtD
Ceftizoxime—Pain—Carboplatin—uterine cancer	0.0122	0.0122	CcSEcCtD
Ceftizoxime—Cellulitis—Etoposide—uterine cancer	0.0118	0.0118	CcSEcCtD
Ceftizoxime—Lactic dehydrogenase activity increased—Epirubicin—uterine cancer	0.0118	0.0118	CcSEcCtD
Ceftizoxime—Body temperature increased—Carboplatin—uterine cancer	0.0113	0.0113	CcSEcCtD
Ceftizoxime—Lactic dehydrogenase activity increased—Doxorubicin—uterine cancer	0.0109	0.0109	CcSEcCtD
Ceftizoxime—Haemoglobin—Progesterone—uterine cancer	0.0106	0.0106	CcSEcCtD
Ceftizoxime—Haemorrhage—Progesterone—uterine cancer	0.0105	0.0105	CcSEcCtD
Ceftizoxime—Blood lactate dehydrogenase increased—Epirubicin—uterine cancer	0.0104	0.0104	CcSEcCtD
Ceftizoxime—Erythema multiforme—Progesterone—uterine cancer	0.00996	0.00996	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Dactinomycin—uterine cancer	0.0097	0.0097	CcSEcCtD
Ceftizoxime—Thrombocytosis—Epirubicin—uterine cancer	0.00968	0.00968	CcSEcCtD
Ceftizoxime—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.0096	0.0096	CcSEcCtD
Ceftizoxime—Blood lactate dehydrogenase increased—Doxorubicin—uterine cancer	0.00958	0.00958	CcSEcCtD
Ceftizoxime—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00955	0.00955	CcSEcCtD
Ceftizoxime—Phlebitis—Etoposide—uterine cancer	0.00905	0.00905	CcSEcCtD
Ceftizoxime—Erythema multiforme—Medroxyprogesterone Acetate—uterine cancer	0.00903	0.00903	CcSEcCtD
Ceftizoxime—Thrombocytosis—Doxorubicin—uterine cancer	0.00895	0.00895	CcSEcCtD
Ceftizoxime—Pancytopenia—Dactinomycin—uterine cancer	0.00884	0.00884	CcSEcCtD
Ceftizoxime—Neutropenia—Dactinomycin—uterine cancer	0.0087	0.0087	CcSEcCtD
Ceftizoxime—Anaemia—Progesterone—uterine cancer	0.00848	0.00848	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Dactinomycin—uterine cancer	0.00823	0.00823	CcSEcCtD
Ceftizoxime—Convulsion—Progesterone—uterine cancer	0.00795	0.00795	CcSEcCtD
Ceftizoxime—Agranulocytosis—Dactinomycin—uterine cancer	0.00774	0.00774	CcSEcCtD
Ceftizoxime—Anaemia—Medroxyprogesterone Acetate—uterine cancer	0.00768	0.00768	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Progesterone—uterine cancer	0.00749	0.00749	CcSEcCtD
Ceftizoxime—Injection site pain—Epirubicin—uterine cancer	0.00737	0.00737	CcSEcCtD
Ceftizoxime—Convulsion—Medroxyprogesterone Acetate—uterine cancer	0.0072	0.0072	CcSEcCtD
Ceftizoxime—Erythema multiforme—Dactinomycin—uterine cancer	0.00704	0.00704	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Etoposide—uterine cancer	0.00702	0.00702	CcSEcCtD
Ceftizoxime—Injection site pain—Doxorubicin—uterine cancer	0.00682	0.00682	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Medroxyprogesterone Acetate—uterine cancer	0.00678	0.00678	CcSEcCtD
Ceftizoxime—Paraesthesia—Progesterone—uterine cancer	0.00672	0.00672	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	0.00664	0.00664	CcSEcCtD
Ceftizoxime—Cellulitis—Epirubicin—uterine cancer	0.00662	0.00662	CcSEcCtD
Ceftizoxime—Pain—Progesterone—uterine cancer	0.0064	0.0064	CcSEcCtD
Ceftizoxime—Pancytopenia—Etoposide—uterine cancer	0.0064	0.0064	CcSEcCtD
Ceftizoxime—Neutropenia—Etoposide—uterine cancer	0.0063	0.0063	CcSEcCtD
Ceftizoxime—Cellulitis—Doxorubicin—uterine cancer	0.00612	0.00612	CcSEcCtD
Ceftizoxime—Paraesthesia—Medroxyprogesterone Acetate—uterine cancer	0.00609	0.00609	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Epirubicin—uterine cancer	0.00602	0.00602	CcSEcCtD
Ceftizoxime—Anaemia—Dactinomycin—uterine cancer	0.00599	0.00599	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Etoposide—uterine cancer	0.00595	0.00595	CcSEcCtD
Ceftizoxime—Body temperature increased—Progesterone—uterine cancer	0.00592	0.00592	CcSEcCtD
Ceftizoxime—Leukopenia—Dactinomycin—uterine cancer	0.0058	0.0058	CcSEcCtD
Ceftizoxime—Vaginal infection—Epirubicin—uterine cancer	0.00568	0.00568	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Epirubicin—uterine cancer	0.00565	0.00565	CcSEcCtD
Ceftizoxime—Agranulocytosis—Etoposide—uterine cancer	0.0056	0.0056	CcSEcCtD
Ceftizoxime—Vaginal inflammation—Doxorubicin—uterine cancer	0.00557	0.00557	CcSEcCtD
Ceftizoxime—Hypersensitivity—Progesterone—uterine cancer	0.00552	0.00552	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Etoposide—uterine cancer	0.00536	0.00536	CcSEcCtD
Ceftizoxime—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	0.00536	0.00536	CcSEcCtD
Ceftizoxime—Pruritus—Progesterone—uterine cancer	0.0053	0.0053	CcSEcCtD
Ceftizoxime—Vaginal infection—Doxorubicin—uterine cancer	0.00526	0.00526	CcSEcCtD
Ceftizoxime—Aplastic anaemia—Doxorubicin—uterine cancer	0.00523	0.00523	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Dactinomycin—uterine cancer	0.00518	0.00518	CcSEcCtD
Ceftizoxime—Diarrhoea—Progesterone—uterine cancer	0.00512	0.00512	CcSEcCtD
Ceftizoxime—Erythema multiforme—Etoposide—uterine cancer	0.0051	0.0051	CcSEcCtD
Ceftizoxime—Phlebitis—Epirubicin—uterine cancer	0.00507	0.00507	CcSEcCtD
Ceftizoxime—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.005	0.005	CcSEcCtD
Ceftizoxime—Pruritus—Medroxyprogesterone Acetate—uterine cancer	0.0048	0.0048	CcSEcCtD
Ceftizoxime—Vomiting—Progesterone—uterine cancer	0.00476	0.00476	CcSEcCtD
Ceftizoxime—Rash—Progesterone—uterine cancer	0.00472	0.00472	CcSEcCtD
Ceftizoxime—Dermatitis—Progesterone—uterine cancer	0.00472	0.00472	CcSEcCtD
Ceftizoxime—Phlebitis—Doxorubicin—uterine cancer	0.00469	0.00469	CcSEcCtD
Ceftizoxime—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.00464	0.00464	CcSEcCtD
Ceftizoxime—Pain—Dactinomycin—uterine cancer	0.00453	0.00453	CcSEcCtD
Ceftizoxime—Nausea—Progesterone—uterine cancer	0.00445	0.00445	CcSEcCtD
Ceftizoxime—Anaemia—Etoposide—uterine cancer	0.00434	0.00434	CcSEcCtD
Ceftizoxime—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.00431	0.00431	CcSEcCtD
Ceftizoxime—Rash—Medroxyprogesterone Acetate—uterine cancer	0.00428	0.00428	CcSEcCtD
Ceftizoxime—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.00427	0.00427	CcSEcCtD
Ceftizoxime—Leukopenia—Etoposide—uterine cancer	0.0042	0.0042	CcSEcCtD
Ceftizoxime—Body temperature increased—Dactinomycin—uterine cancer	0.00418	0.00418	CcSEcCtD
Ceftizoxime—Convulsion—Etoposide—uterine cancer	0.00407	0.00407	CcSEcCtD
Ceftizoxime—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.00403	0.00403	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Epirubicin—uterine cancer	0.00393	0.00393	CcSEcCtD
Ceftizoxime—Hypersensitivity—Dactinomycin—uterine cancer	0.0039	0.0039	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Etoposide—uterine cancer	0.00383	0.00383	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Etoposide—uterine cancer	0.00375	0.00375	CcSEcCtD
Ceftizoxime—Eosinophilia—Epirubicin—uterine cancer	0.00374	0.00374	CcSEcCtD
Ceftizoxime—Toxic epidermal necrolysis—Doxorubicin—uterine cancer	0.00364	0.00364	CcSEcCtD
Ceftizoxime—Diarrhoea—Dactinomycin—uterine cancer	0.00362	0.00362	CcSEcCtD
Ceftizoxime—Pancytopenia—Epirubicin—uterine cancer	0.00359	0.00359	CcSEcCtD
Ceftizoxime—Neutropenia—Epirubicin—uterine cancer	0.00353	0.00353	CcSEcCtD
Ceftizoxime—Eosinophilia—Doxorubicin—uterine cancer	0.00346	0.00346	CcSEcCtD
Ceftizoxime—Paraesthesia—Etoposide—uterine cancer	0.00344	0.00344	CcSEcCtD
Ceftizoxime—Vomiting—Dactinomycin—uterine cancer	0.00336	0.00336	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Epirubicin—uterine cancer	0.00334	0.00334	CcSEcCtD
Ceftizoxime—Rash—Dactinomycin—uterine cancer	0.00334	0.00334	CcSEcCtD
Ceftizoxime—Pancytopenia—Doxorubicin—uterine cancer	0.00332	0.00332	CcSEcCtD
Ceftizoxime—Pain—Etoposide—uterine cancer	0.00328	0.00328	CcSEcCtD
Ceftizoxime—Neutropenia—Doxorubicin—uterine cancer	0.00327	0.00327	CcSEcCtD
Ceftizoxime—Nausea—Dactinomycin—uterine cancer	0.00314	0.00314	CcSEcCtD
Ceftizoxime—Agranulocytosis—Epirubicin—uterine cancer	0.00314	0.00314	CcSEcCtD
Ceftizoxime—Stevens-Johnson syndrome—Doxorubicin—uterine cancer	0.00309	0.00309	CcSEcCtD
Ceftizoxime—Haemoglobin—Epirubicin—uterine cancer	0.00304	0.00304	CcSEcCtD
Ceftizoxime—Body temperature increased—Etoposide—uterine cancer	0.00303	0.00303	CcSEcCtD
Ceftizoxime—Haemorrhage—Epirubicin—uterine cancer	0.00302	0.00302	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Epirubicin—uterine cancer	0.00301	0.00301	CcSEcCtD
Ceftizoxime—Agranulocytosis—Doxorubicin—uterine cancer	0.00291	0.00291	CcSEcCtD
Ceftizoxime—Erythema multiforme—Epirubicin—uterine cancer	0.00286	0.00286	CcSEcCtD
Ceftizoxime—Hypersensitivity—Etoposide—uterine cancer	0.00282	0.00282	CcSEcCtD
Ceftizoxime—Haemoglobin—Doxorubicin—uterine cancer	0.00281	0.00281	CcSEcCtD
Ceftizoxime—Haemorrhage—Doxorubicin—uterine cancer	0.0028	0.0028	CcSEcCtD
Ceftizoxime—Hypoaesthesia—Doxorubicin—uterine cancer	0.00278	0.00278	CcSEcCtD
Ceftizoxime—Pruritus—Etoposide—uterine cancer	0.00271	0.00271	CcSEcCtD
Ceftizoxime—Erythema multiforme—Doxorubicin—uterine cancer	0.00264	0.00264	CcSEcCtD
Ceftizoxime—Diarrhoea—Etoposide—uterine cancer	0.00262	0.00262	CcSEcCtD
Ceftizoxime—Vomiting—Etoposide—uterine cancer	0.00244	0.00244	CcSEcCtD
Ceftizoxime—Anaemia—Epirubicin—uterine cancer	0.00243	0.00243	CcSEcCtD
Ceftizoxime—Rash—Etoposide—uterine cancer	0.00241	0.00241	CcSEcCtD
Ceftizoxime—Dermatitis—Etoposide—uterine cancer	0.00241	0.00241	CcSEcCtD
Ceftizoxime—Leukopenia—Epirubicin—uterine cancer	0.00235	0.00235	CcSEcCtD
Ceftizoxime—Convulsion—Epirubicin—uterine cancer	0.00228	0.00228	CcSEcCtD
Ceftizoxime—Nausea—Etoposide—uterine cancer	0.00228	0.00228	CcSEcCtD
Ceftizoxime—Anaemia—Doxorubicin—uterine cancer	0.00225	0.00225	CcSEcCtD
Ceftizoxime—Leukopenia—Doxorubicin—uterine cancer	0.00218	0.00218	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Epirubicin—uterine cancer	0.00215	0.00215	CcSEcCtD
Ceftizoxime—Convulsion—Doxorubicin—uterine cancer	0.00211	0.00211	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Epirubicin—uterine cancer	0.0021	0.0021	CcSEcCtD
Ceftizoxime—Anaphylactic shock—Doxorubicin—uterine cancer	0.00199	0.00199	CcSEcCtD
Ceftizoxime—Thrombocytopenia—Doxorubicin—uterine cancer	0.00195	0.00195	CcSEcCtD
Ceftizoxime—Paraesthesia—Epirubicin—uterine cancer	0.00193	0.00193	CcSEcCtD
Ceftizoxime—Pain—Epirubicin—uterine cancer	0.00184	0.00184	CcSEcCtD
Ceftizoxime—Paraesthesia—Doxorubicin—uterine cancer	0.00178	0.00178	CcSEcCtD
Ceftizoxime—Pain—Doxorubicin—uterine cancer	0.0017	0.0017	CcSEcCtD
Ceftizoxime—Body temperature increased—Epirubicin—uterine cancer	0.0017	0.0017	CcSEcCtD
Ceftizoxime—Hypersensitivity—Epirubicin—uterine cancer	0.00158	0.00158	CcSEcCtD
Ceftizoxime—Body temperature increased—Doxorubicin—uterine cancer	0.00157	0.00157	CcSEcCtD
Ceftizoxime—Pruritus—Epirubicin—uterine cancer	0.00152	0.00152	CcSEcCtD
Ceftizoxime—Diarrhoea—Epirubicin—uterine cancer	0.00147	0.00147	CcSEcCtD
Ceftizoxime—Hypersensitivity—Doxorubicin—uterine cancer	0.00146	0.00146	CcSEcCtD
Ceftizoxime—Pruritus—Doxorubicin—uterine cancer	0.00141	0.00141	CcSEcCtD
Ceftizoxime—Vomiting—Epirubicin—uterine cancer	0.00137	0.00137	CcSEcCtD
Ceftizoxime—Diarrhoea—Doxorubicin—uterine cancer	0.00136	0.00136	CcSEcCtD
Ceftizoxime—Rash—Epirubicin—uterine cancer	0.00135	0.00135	CcSEcCtD
Ceftizoxime—Dermatitis—Epirubicin—uterine cancer	0.00135	0.00135	CcSEcCtD
Ceftizoxime—Nausea—Epirubicin—uterine cancer	0.00128	0.00128	CcSEcCtD
Ceftizoxime—Vomiting—Doxorubicin—uterine cancer	0.00126	0.00126	CcSEcCtD
Ceftizoxime—Rash—Doxorubicin—uterine cancer	0.00125	0.00125	CcSEcCtD
Ceftizoxime—Dermatitis—Doxorubicin—uterine cancer	0.00125	0.00125	CcSEcCtD
Ceftizoxime—Nausea—Doxorubicin—uterine cancer	0.00118	0.00118	CcSEcCtD
